Ossulin™ Oral Insulin Data To Be Presented At The San Francisco Diabetes Congress On November 6, 2009

Fri, 06 Nov 2009 13:00:00 PST
http://www.medicalnewstoday.com/articles/170138.php

The first public data on Ossulin™ a new oral insulin product, will be presented today at the 9th Annual Diabetes Technology Meeting in San Francisco, CA. Ossulin™ is being developed by Puredel Limited, a joint-venture between the European pharmaceutical specialty company CM&D Pharma Limited and Natreon Inc., New Brunswick, NJ., developers of the proprietary delivery platform (

ARKRAY, Inc. Receives FDA Clearance For New GLUCOCARD(R) Vital(TM) Blood Glucose Monitoring System

Fri, 06 Nov 2009 02:00:00 PST
http://www.medicalnewstoday.com/articles/170044.php

ARKRAY, Inc., the world's 5th largest manufacturer of diabetes self-monitoring systems, announced that it has received 510(k) clearance from the US Food and Drug Administration for its new GLUCOCARD Vital blood glucose monitoring system.

World Diabetes Day - 14 November (Ways You Can Cover The UN Day In Your Country And Globally)

Fri, 06 Nov 2009 01:00:00 PST
http://www.medicalnewstoday.com/articles/170022.php

According to latest data released by the International Diabetes Federation (IDF), diabetes now affects 285 million people worldwide costs the world economy at least US$376 billion in 2010, or 11.6% of total world healthcare expenditure. A further 344 million are at risk of developing diabetes (pre-diabetes). If nothing is done to reverse the epidemic, IDF predicts that by 2030, 435 million people will live with the disease as at a cost projected to exceed US$490 billion.

As America Earns Failing Grade, American Diabetes Association Launches Movement To Stop Diabetes

Thu, 05 Nov 2009 11:00:00 PST
http://www.medicalnewstoday.com/articles/169972.php

Americans earn a failing grade on diabetes awareness, based on survey results released today by the American Diabetes Association. In general, Americans earned a 51% when asked a series of questions about a disease so common that it strikes every 20 seconds. The survey results revealed that many diabetes myths and misconceptions still exist, while the disease's prevalence continues to rise.

My Voice Milestone - Diabetes UK

Thu, 05 Nov 2009 03:00:00 PST
http://www.medicalnewstoday.com/articles/169940.php

Since the October launch of My Voice - Diabetes UK's campaigners network for the under-18s - more than 100 young people and children have become members. Raj Johal, Local Campaigns Officer at Diabetes UK, said: "We're delighted with the response to the My Voice network as we feel that engaging young people and children in the arena of campaigning and lobbying is very important.

Wide-Ranging Medicinal Uses For American Ginseng To Be Explored At Conference

Thu, 05 Nov 2009 02:00:00 PST
http://www.medicalnewstoday.com/articles/169928.php

With the current outbreak of influenza-like illnesses, many people are trying to boost their immune systems with supplements. Ginseng is often a key ingredient, but its therapeutic use may extend far beyond that. Researchers are now investigating whether ginseng can help relieve health problems ranging from diabetes to depression to erectile dysfunction.

IDF Guideline On Oral Health For People With Diabetes Supported By AAP

Wed, 04 Nov 2009 05:00:00 PST
http://www.medicalnewstoday.com/articles/169833.php

New clinical guidelines released by the International Diabetes Foundation (IDF) emphasize the importance of periodontal health for people with diabetes. Diabetes affects approximately 246 million people worldwide, and this number is only expected to increase. The IDF is an organization of 200 national diabetes associations from 160 countries.

A 'Spoonful Of Sugar' Makes The Worms' Life Span Go Down

Wed, 04 Nov 2009 04:00:00 PST
http://www.medicalnewstoday.com/articles/169764.php

If worms are any indication, all the sugar in your diet could spell much more than obesity and type 2 diabetes. Researchers reporting in the November issue of Cell Metabolism, a Cell Press publication, say it might also be taking years off your life. By adding just a small amount of glucose to C. elegans usual fare of straight bacteria, they found the worms lose about 20 percent of their usual life span.

Preventing Saturated Fatty Acids From 'Angering' The Immune System

Wed, 04 Nov 2009 04:00:00 PST
http://www.medicalnewstoday.com/articles/169765.php

Researchers have new evidence to explain how saturated fatty acids, which soar in those who are obese, can lead the immune system to respond in ways that add up to chronic, low-grade inflammation. The new results could lead to treatments designed to curb that inflammatory state, and the insulin resistance and type 2 diabetes that come with it.

Researchers Identify The Three Killer Indicators That Are Even Worse Than High Cholesterol

Wed, 04 Nov 2009 00:00:00 PST
http://www.medicalnewstoday.com/articles/169682.php

Researchers at the University of Warwick have identified a particular combination of health problems that can double the risk of heart attack and cause a three-fold increase in the risk of mortality.

Fruit Fly Model Created To Help Unravel Genetics Of Human Diabetes

Wed, 04 Nov 2009 00:00:00 PST
http://www.medicalnewstoday.com/articles/169692.php

As rates of obesity, diabetes, and related disorders have reached epidemic proportions in the US in recent years, scientists are working from many angles to pinpoint the causes and contributing factors involved in this public health crisis. While sedentary lifestyles and diets high in sugar and fat contribute significantly to the rise in diabetes rates, genetic factors may make some people more vulnerable than others to developing diabetes.

Pharmacists Positioned To Help Patients With Diabetes Management

Tue, 03 Nov 2009 09:00:00 PST
http://www.medicalnewstoday.com/articles/169643.php

An estimated 1.8 million Canadians are currently living with diabetes and that number that is rapidly growing. Chronic diseases, like diabetes, put a huge burden on the Canadian health care system and the direct costs to the system, from diabetes alone, are expected to exceed $15 billion by next year. Pharmacists play an important role in diabetes management and are positioned to take on even greater responsibilities.

Inhaled Nitric Oxide Therapy For Preemies: Disappointing Early Results Of Multicenter Study

Tue, 03 Nov 2009 06:00:00 PST
http://www.medicalnewstoday.com/articles/169679.php

Inhaled nitric oxide (iNO), a therapy used in the treatment of premature newborns with respiratory failure that had shown promising results in short-term studies, does not significantly improve long-term outcomes, according to a national study led by critical care researchers at the University of Pittsburgh School of Medicine and Children's Hospital of Pittsburgh of UPMC.

Lifestyle Changes May Stave Off Diabetes For A Decade

Tue, 03 Nov 2009 02:00:00 PST
http://www.medicalnewstoday.com/articles/169570.php

Sustaining modest weight loss for 10 years, or taking an anti-diabetic drug over that time, can prevent or lower the incidence of type 2 diabetes in people at high risk for developing the disease, according to the Diabetes Prevention Program Outcomes Study (DPPOS), a long-term follow-up to a landmark 2001 diabetes prevention study. Jill Crandall, M.D.

Abbott's XIENCE PRIME™ And XIENCE V(R) Receive Indications In Europe For Treatment Of Patients With Diabetes

Tue, 03 Nov 2009 01:00:00 PST
http://www.medicalnewstoday.com/articles/169550.php

Abbott announced that both the XIENCE PRIME™ Everolimus Eluting Coronary Stent System1 and the XIENCE V® Everolimus Eluting Coronary Stent System have received additional new CE Markings (Conformité Européenne) covering the treatment of patients with diabetes. Receiving these new indications among the European Union Member States validates the use of XIENCE PRIME and XIENCE V to treat patients with diabetes.

Amylin Pharmaceuticals And Eli Lilly And Company Statement On FDA's BYETTA(R) (Exenatide) Injection Update

Tue, 03 Nov 2009 01:00:00 PST
http://www.medicalnewstoday.com/articles/169554.php

Amylin Pharmaceuticals, Inc., (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) issued the following statement in response to the U.S. Food and Drug Administration (FDA) update on BYETTA® (exenatide) injection. "The FDA update issued today aligns with the BYETTA label approved last week. The current label reflects our understanding of post-marketing reports of renal events and provides physicians with updated guidance about appropriate use in patients with renal conditions.

Men Twice As Likely Not To Know They Have Diabetes

Tue, 03 Nov 2009 00:00:00 PST
http://www.medicalnewstoday.com/articles/169528.php

New research suggests men over 50 are nearly twice as likely to have undiagnosed Type 2 diabetes than their female counterparts, warns Diabetes UK today. Published in the journal Diabetic Medicine, a nationally representative study of 6,739 52- to 79-year-olds found 502 to have diabetes. Of the men with diabetes, 22 per cent did not realise they had the condition before the study, compared to 12 per cent of the women.

Human Clinical Study Finds Benefits Linked To XanGo Juice

Tue, 03 Nov 2009 00:00:00 PST
http://www.medicalnewstoday.com/articles/169529.php

A new study published in Nutrition Journal indicates that XanGo® Juice, a market-leading, premium mangosteen beverage, has lowered levels of C-reactive protein (CRP) in overweight and obese people in a randomized, double-blind, placebo-controlled human trial.

Over 1,000 Get Serious In First Week, Diabetes UK

Tue, 03 Nov 2009 00:00:00 PST
http://www.medicalnewstoday.com/articles/169538.php

By the end of the first week of the Get Serious campaign, more than 1,000 people had logged on, signed up and made pledges for Diabetes UK. In making diabetes a priority, our supporters are starting to help us raise the profile of how serious diabetes is and how, as one collective voice, we can fight the UK's biggest health challenge. Community grows The Get Serious community continues to grow each day along with the variety of pledges.

New Targets Found For Preventing Diabetes Complications

Mon, 02 Nov 2009 05:00:00 PST
http://www.medicalnewstoday.com/articles/169511.php

In diabetes patients, high blood glucose levels can end up killing certain cells in the eyes and kidneys, which is why diabetes is the leading cause of adult blindness and of kidney failure. Years ago, scientists identified one main route for this destruction-high glucose produces oxidative stress through the NF-kB molecular pathway-but success has been elusive for drugs targeting that pathway.

American Academy Of Ophthalmology Announces New Drive For Thousands To Get Diabetic Eye Exam

Sun, 01 Nov 2009 00:00:00 PST
http://www.medicalnewstoday.com/articles/169362.php

Diabetes causes more new cases of legal blindness among working-age Americans than any other disease. If diabetics are monitored regularly by their ophthalmologist, this vision loss is almost always avoidable. Yet, tragically, more than half of all people living with diabetes do not get the recommended annual dilated eye exam. As the number of people with Type 2 diabetes rises in the U.S., the CDC projects that the number of adults with diabetic retinopathy will double by the year 2050.

New European Commission Directive Affecting Drivers With Diabetes

Sun, 01 Nov 2009 00:00:00 PST
http://www.medicalnewstoday.com/articles/169375.php

The European Commission (EC) has passed a directive which could introduce individual assessments for people with insulin-treated diabetes to hold Group 2 driving licences. These licences cover large goods vehicles (LGVs) and vehicles carrying more than six passengers. Current blanket ban The UK currently has a blanket ban on all insulin-treated drivers of Group 2 vehicles, except for Category 1 (C1) licence holders.

Healthy Weight And Regular Physical Activity Could Prevent Diabetes For A Decade Says New Research

Sun, 01 Nov 2009 00:00:00 PST
http://www.medicalnewstoday.com/articles/169376.php

New research suggests that a period of careful eating and regular physical activity could prevent diabetes for up to a decade. US researchers followed up nearly 3,000 overweight people who had taken part in a three-year diabetes prevention programme. They had initially been divided into three groups, one undertaking a diet and exercise programme, the second taking metformin and the third a placebo. The report noted it was the dieters who reaped the most benefit.

ESC Events In Asia Tackle Management Of Diabetes And Cardiovascular Disease

Sat, 31 Oct 2009 02:00:00 PST
http://www.medicalnewstoday.com/articles/169393.php

With the rapidly increasing problem of cardiovascular (CVD) disease in Asia Pacific (AP), there is an urgency to raise awareness of risk factors. The European Society of Cardiology (ESC) is addressing the need to develop and adopt an integrated approach to CVD management, through important events organised in the region. CVD has become more prevalent in India and China than in all of the economically-developed countries in the world combined.

BYETTA Approved For Expanded Use As First-Line Treatment For Type 2 Diabetes

Sat, 31 Oct 2009 02:00:00 PST
http://www.medicalnewstoday.com/articles/169396.php

Amylin Pharmaceuticals, Inc., (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for BYETTA® (exenatide) injection. BYETTA is now approved for use as a stand-alone medication (monotherapy) along with diet and exercise to improve glycemic control in adults with type 2 diabetes.